Patent · US Active

Anti-TMEFF1 antibodies and antibody drug conjugates

US11312769B2 · kind B2 · utility

1Cited by

0References

14Claims

0Family size

Assignee

Bluefin BioMedicine, Inc · US

Inventors

Isabel Milan Chu · Lexington, US
Scott Michael Lonning · Westford, US
Nels Eric Pederson · Mansfield, US
Klarisa Rikova · Reading, US
Aleksandr Tkachev · Cambridge, US
Jason G. Beaudet · Beverly, US

Key dates

Filing date	Mar 22, 2018
Grant date	Apr 26, 2022
Priority date	—
Expiry date	Jun 27, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are transmembrane protein with EGF-like and two-follistatin-like domains 1 (TMEFF1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.